| Literature DB >> 29575175 |
Yinyun Ni1, Sisi Wu1,2, Xiangxiu Wang1, Guonian Zhu1, Xuemei Chen1, Yu Ding1, Wei Jiang2.
Abstract
Natural products are a great source of cancer chemotherapeutic agents. In the present study, the anticancer effects of cucurbitacin I on A549 cells were investigated. Cucurbitacin I decreased cell viability, inhibited colony formation, and induced apoptosis in A549 cells. Cucurbitacin I caused accumulation of autophagosome and dose-dependent expression of LC3II protein. Autophagy inhibitors 3-methyladenine (3-MA) inhibited autophagy induced by cucurbitacin I and relieved cucurbitacin I-triggered cell death and apoptosis in A549 Cells. Cucurbitacin I treatment inhibits the ERK activation and the downstream phosphorylation level of mTOR and STAT3, but not the PI3K/Akt pathway. Furthermore, treatment with the mTOR activator MHY-1485, which also suppressed cucurbitacin I-induced LC3II expression, and also reversed cucurbitacin I-induced cell death and apoptosis. Taken together, these results suggest that cucurbitacin I induced pro-death autophagy through ERK/mTOR/STAT3 signaling cascade in A549 cells.Entities:
Keywords: apoptosis; autophagy; cell viability; cucurbitacin I; mTOR
Mesh:
Substances:
Year: 2018 PMID: 29575175 DOI: 10.1002/jcb.26808
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429